|
ELMOD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.282600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.037500E-02 |
| Normal-vs-Stage2 |
9.635000E-01 |
| Normal-vs-Stage3 |
7.820600E-04 |
| Normal-vs-Stage4 |
1.849370E-04 |
| Stage1-vs-Stage2 |
4.003600E-01 |
| Stage1-vs-Stage3 |
2.014500E-02 |
| Stage1-vs-Stage4 |
6.904400E-03 |
| Stage2-vs-Stage3 |
3.245700E-02 |
| Stage2-vs-Stage4 |
4.156200E-02 |
| Stage3-vs-Stage4 |
8.811600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.216500E-03 |
| Normal-vs-AfricanAmerican |
3.789100E-04 |
| Normal-vs-Asian |
2.970600E-01 |
| Caucasian-vs-AfricanAmerican |
9.284200E-02 |
| Caucasian-vs-Asian |
9.979400E-01 |
| AfricanAmerican-vs-Asian |
5.037800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.456700E-03 |
| Normal-vs-Female |
1.136420E-02 |
| Male-vs-Female |
6.790400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.573800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.028400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.684000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.144390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.808500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.075010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.503180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.161200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.473400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.146400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.275600E-01 |
| Normal-vs-Grade 2 |
2.850600E-01 |
| Normal-vs-Grade 3 |
1.035270E-03 |
| Normal-vs-Grade 4 |
1.40389999625512E-08 |
| Grade 1-vs-Grade 2 |
8.798200E-01 |
| Grade 1-vs-Grade 3 |
2.119600E-01 |
| Grade 1-vs-Grade 4 |
6.717700E-03 |
| Grade 2-vs-Grade 3 |
3.287800E-02 |
| Grade 2-vs-Grade 4 |
1.52279999999783E-05 |
| Grade 3-vs-Grade 4 |
2.661700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.526200E-01 |
| Normal-vs-ccB subtype |
5.901500E-03 |
| ccA subtype-vs-ccB subtype |
2.893700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.576500E-02 |
| Normal-vs-N1 |
2.240100E-02 |
| N0-vs-N1 |
4.212200E-01 |
|
|
